Diagnosing schistosomiasis-induced liver morbidity: implications for global control

Background: Subclinical morbidity due to schistosomiasis was evaluated in 565 patients, and the enhanced liver fibrosis (ELF) test was assessed for the first time as a potential screening tool for disease. Methods: The prevalence and intensity of infection were determined by Kato–Katz thick smear st...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: David U. Olveda, Marianette Inobaya, Remigio M. Olveda, Marilyn L. Vinluan, Shu-Kay Ng, Kosala Weerakoon, Donald P. McManus, Grant A. Ramm, Donald A. Harn, Yuesheng Li, Alfred K. Lam, Jerric R. Guevarra, Allen G. Ross
Format: Artigo
Langue:Inglês
Publié: Elsevier 2017-01-01
Collection:International Journal of Infectious Diseases
Sujets:
Schistosomiasis
Morbidity
Ultrasound
Liver fibrosis
Serum makers
Accès en ligne:http://www.sciencedirect.com/science/article/pii/S1201971216312085
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires